earnings beatDERMfinnhub
Journey Medical (DERM) Beats Q2 Earnings Estimates by $0.01
Journey Medical (NASDAQ:DERM) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreFeatured By
Real-time context
Company earnings results and notable reporting developments.
Journey Medical (NASDAQ:DERM) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreKura Oncology (NASDAQ:KURA) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreCyngn (NASDAQ:CYN) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreBioCardia (NASDAQ:BCDA) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreTalphera (NASDAQ:TLPH) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreLeslies (NASDAQ:LESL) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreWestern Forest Products (NASDAQ:WEF) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreOmeros (NASDAQ:OMER) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read morePerma-Fix Envirn Servs (NASDAQ:PESI) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreBeasley Broadcast Group (NASDAQ:BBGI) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreT1 Energy (NYSE:TE) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreMonopar Therapeutics (NASDAQ:MNPR) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreAprea Therapeutics (NASDAQ:APRE) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreSPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. (NASDAQ:SPRB) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreAtara Biotherapeutics (NASDAQ:ATRA) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreArmata Pharmaceuticals (AMEX:ARMP) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreArriVent BioPharma (NASDAQ:AVBP) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreCocrystal Pharma, Inc. (NASDAQ:COCP) is scheduled to report its Q2 earnings results on August 13, 2026 after market close.
Read moreDaré Bioscience, Inc. (NASDAQ:DARE) is scheduled to report its Q2 earnings results on August 13, 2026 after market close.
Read moreDragonfly Energy Holdings Corp. (NASDAQ:DFLI) is scheduled to report its Q2 earnings results on August 13, 2026 after market close.
Read more